Chiasma Inc Revenue Growth Rates (CHMA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Chiasma Inc   (NASDAQ: CHMA)
 

CHMA's Revenue Growth by Quarter and Year

Chiasma Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CHMA Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 1.92
FY 1.92





CHMA Revenue first quarter 2021 Y/Y Growth Comment
Chiasma Inc in the first quarter 2021 achieved Revenue of $ 1.92 millions compare to recorded in same quarter a year ago.

Looking into first quarter 2021 results within Major Pharmaceutical Preparations industry 34 other companies have achieved higher Revenue growth. While Chiasma Inc ' s Revenue no change of 0% ranks overall at the positon no. 208 in the first quarter 2021.


CHMA Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Chiasma Inc 's first quarter 2021 Revenue $ 1.92 millions CHMA's Income Statement
Chiasma Inc 's first quarter 2020 Revenue $ 0.00 millions Quarterly CHMA's Income Statement


CHMA Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December - 585.71 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March 100.42 % - - -
FY (Year on Year)   - - - -


Back to CHMA Growth rate Comparisons >> Back to CHMA Growth rate Comparisons >>


Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #35
Healthcare Sector #62
Overall #208

Revenue Y/Y Growth Statistics
High Average Low
578.87 % 339.23 % 99.59 %
(Dec 31 2020)   (Mar 31 2021)
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #35
Healthcare Sector #62
Overall #208
Revenue Y/Y Growth Statistics
High Average Low
578.87 % 339.23 % 99.59 %
(Dec 31 2020)   (Mar 31 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Chiasma Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
578.87 % 339.23 % 99.59 %
(Dec 31 2020)  


CHMA's I. Quarter Q/Q Revenue Comment
Chiasma Inc achieved in the I. Quarter 2021 below company average Revenue doubling of 100.42% quarter on quarter, to $ 1.92 millions.

I. Quarter 2021 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the I. Quarter a year ago.

Within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Chiasma Inc 's Revenue growth quarter on quarter, overall rank is 219.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #65
Overall #219
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #37
Healthcare Sector #65
Overall #219
Revenue Q/Q Growth Statistics
High Average Low
578.87 % 339.23 % 99.59 %
(Dec 31 2020)  


CHMA's I. Quarter Q/Q Revenue Comment
Chiasma Inc achieved in the I. Quarter 2021 below company average Revenue doubling of 100.42% quarter on quarter, to $ 1.92 millions.

I. Quarter 2021 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the I. Quarter a year ago.

Within Major Pharmaceutical Preparations industry 36 other companies have achieved higher Revenue quarter on quarter growth. While Chiasma Inc 's Revenue growth quarter on quarter, overall rank is 219.


Chiasma Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)		 12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2021 period, Chiasma Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Chiasma Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2021 period, Chiasma Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Chiasma Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CHMA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Neurocrine Biosciences Inc -0.21%$ -0.211 millions
U S Physical Therapy Inc-0.31%$ -0.310 millions
Community Health Systems Inc -0.40%$ -0.397 millions
Davita Inc -0.75%$ -0.747 millions
Travere Therapeutics Inc -0.76%$ -0.758 millions
Neurometrix Inc -0.76%$ -0.763 millions
Amneal Pharmaceuticals Inc -0.80%$ -0.799 millions
Escalon Medical Corp -1.38%$ -1.378 millions
Allied Healthcare Products inc -1.61%$ -1.607 millions
Inogen Inc -1.76%$ -1.760 millions
Carlisle Companies Incorporated-1.91%$ -1.908 millions
National Healthcare Corp-2.01%$ -2.011 millions
Tactile Systems Technology Inc -2.07%$ -2.068 millions
Eyepoint Inc -2.22%$ -2.217 millions
Rockwell Medical inc -2.42%$ -2.419 millions
Old Ayala Inc -2.70%$ -2.697 millions
Inspiremd Inc -2.71%$ -2.708 millions
Mimedx Group Inc -2.87%$ -2.865 millions
Bioadaptives Inc -2.94%$ -2.943 millions
Anika Therapeutics Inc -3.12%$ -3.122 millions
Biomarin Pharmaceutical Inc-3.19%$ -3.195 millions
Icu Medical Inc-3.21%$ -3.214 millions
Horizon Therapeutics Public Limited Company-3.79%$ -3.794 millions
Amgen Inc -4.22%$ -4.220 millions
Fuse Medical Inc -4.22%$ -4.222 millions
Vaso Corporation-4.42%$ -4.421 millions
Stablecoin Development Corporation-4.49%$ -4.493 millions
Cidara Therapeutics Inc -4.82%$ -4.822 millions
Guardion Health Sciences Inc -5.06%$ -5.057 millions
Prestige Consumer Healthcare Inc -5.36%$ -5.363 millions


About Chiasma Inc Revenue Growth Rates (CHMA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.